MG
CELU icon

Michael Gelband’s Celularity CELU Stock Holding History

Michael Gelband’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,673
Closed -$57K – 1919
2022
Q2 		$57K Sell
1,673
-3,968
-70% -$322K ﹤0.01% 1789
2022
Q1 		$491K Buy
5,641
+3,365
+148% +$202K 0.01% 1544
2021
Q4 		$117K Buy
+2,276
New +$146K ﹤0.01% 1931

Other funds holding CELU

SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
CVSC
C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LDFO
Louis-Dreyfus Family Office Wilton, Connecticut $64.7M AUM 21.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Michael Gelband's CELU Position: Q3 2022 in Review

Michael Gelband sold out of Celularity (CELU) in Q3 2022, closing a stake of 1,673 shares — an estimated $57K sold.

Michael Gelband first reported a position in CELU in Q4 2021 and held it in 3 quarters. The position peaked at $491K in Q1 2022. 72 funds tracked by Wall St. Rank hold CELU as of Q3 2022.

  • Michael Gelband reported no remaining Celularity position as of Q3 2022 after selling out during the quarter.
  • Michael Gelband sold 1,673 Celularity shares in Q3 2022, an estimated $57K.
  • Michael Gelband first reported a position in Celularity in Q4 2021 and held it in 3 quarters.
  • Michael Gelband's Celularity position peaked at $491K in Q1 2022.
  • 72 funds tracked by Wall St. Rank held Celularity as of Q3 2022.

Based on ExodusPoint Capital Management's 13F filing for Q3 2022, filed 10 Nov 2022.